In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent TemozolomideWHOON JONG KIL; CERNA, David; BURGAN, William E et al.Clinical cancer research. 2008, Vol 14, Num 3, pp 931-938, issn 1078-0432, 8 p.Article

Temozolomide: A Safe and Effective Treatment for Malignant Digestive Endocrine TumorsMAIRE, Frédérique; HAMMEL, Pascal; RUSZNIEWSKI, Philippe et al.Neuroendocrinology (Basel). 2009, Vol 90, Num 1, pp 67-72, issn 0028-3835, 6 p.Article

Cooperative function of Chk1 and p38 pathways in activating G₂ arrest following exposure to temozolomideHIROSE, Yuichi; KATAYAMA, Makoto; BERGER, Mitchel S et al.Journal of neurosurgery. 2004, Vol 100, Num 6, pp 1060-1065, issn 0022-3085, 6 p.Article

Chemotherapy-Associated Steatohepatitis with Temozolomide and DexamethasoneMILLER, Robert J. H; XIANYONG GUI; EASAW, Jacob C et al.Canadian journal of neurological sciences. 2012, Vol 39, Num 4, pp 547-549, issn 0317-1671, 3 p.Article

Treatment of Nelson's syndrome with temozolomideMOYES, V. J; ALUSI, G; SABIN, H. I et al.European journal of endocrinology. 2009, Vol 160, Num 1, pp 115-119, issn 0804-4643, 5 p.Article

Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosisFRANCESCHI, Enrico; CAVALLO, Giovanna; SCOPECE, Luciano et al.Journal of neuro-oncology. 2005, Vol 73, Num 3, pp 261-264, issn 0167-594X, 4 p.Article

Chemotherapy as initial treatment in gliomatosis cerebri: Results with temozolomideLEVIN, Netta; GOMORI, John Moshe; SIEGAL, Tali et al.Neurology. 2004, Vol 63, Num 2, pp 354-356, issn 0028-3878, 3 p.Article

A Rare Case of Aplastic Anemia Caused by TemozolomideGEORGE, Benjamin J; EICHINGER, Jessica B; RICHARD, Thomas J et al.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 9, pp 974-976, issn 0038-4348, 3 p.Article

Temozolomide in the treatment of solid tumours: current results and rationale for dosing/schedulingPAYNE, M. J; PRATAP, S. E; MIDDLETON, M. R et al.Critical reviews in oncology/hematology. 2005, Vol 53, Num 3, pp 241-252, issn 1040-8428, 12 p.Article

The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell deathTRIVEDI, Ram N; ALMEIDA, Karen H; FORNSAGLIO, Jamie L et al.Cancer research (Baltimore). 2005, Vol 65, Num 14, pp 6394-6400, issn 0008-5472, 7 p.Article

One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastomaWICK, W; STEINBACH, J. P; KÜKER, W. M et al.Neurology. 2004, Vol 62, Num 11, pp 2113-2115, issn 0028-3878, 3 p.Article

Combined treatment with temozolomide and methoxyamine : Blocking apurininc/pyrimidinic site repair coupled with targeting topoisomerase IIαLINGYAN; BULGAR, Alina; YANLING MIAO et al.Clinical cancer research. 2007, Vol 13, Num 5, pp 1532-1539, issn 1078-0432, 8 p.Article

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrinetumorsEKEBLAD, Sara; SUNDIN, Anders; OBERG, Kjell et al.Clinical cancer research. 2007, Vol 13, Num 10, pp 2986-2991, issn 1078-0432, 6 p.Article

Adenovirally delivered tumor necrosis factor-a improves the antiglioma efficacy of concomitant radiation and temozolomide therapyYAMINI, Bakhtiar; XIAOHONG YU; PYTEL, Peter et al.Clinical cancer research. 2007, Vol 13, Num 20, pp 6217-6223, issn 1078-0432, 7 p.Article

Is protracted low-dose temozolomide feasible in glioma patients?TOSONI, A; CAVALLO, G; ERMANI, M et al.Neurology. 2006, Vol 66, Num 3, pp 427-429, issn 0028-3878, 3 p.Article

Optimizing a novel regional chemotherapeutic agent against melanoma : Hyperthermia-induced enhancement of temozolomide cytotoxicitySAE HEE KO; UENO, Tomio; TYLER, Douglas S et al.Clinical cancer research. 2006, Vol 12, Num 1, pp 289-297, issn 1078-0432, 9 p.Article

A phase I trial of protracted oral fixed-dose temozolomideJONES, Suzanne F; GRECO, F. Anthony; GIAN, Victor G et al.Cancer. 2005, Vol 104, Num 9, pp 1985-1991, issn 0008-543X, 7 p.Article

MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in GliomaLI, Rui-Yan; CHEN, Ling-Chao; YANG, Dong-Bo et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 7, pp 477-483, issn 1755-5930, 7 p.Article

Temozolomide-Mediated DNA Methylation in Human Myeloid Precursor Cells: Differential Involvement of Intrinsic and Extrinsic Apoptotic PathwaysHAIYAN WANG; SHANBAO CAI; SHOKOLENKOC, Inna et al.Clinical cancer research (Print). 2013, Vol 19, Num 10, pp 2699-2709, issn 1078-0432, 11 p.Article

Disseminated salmonellosis in a patient treated with temozolomideGEORGESCU, Georgiana; ISOLA, Ignatio M; YOUSSEF, Souad et al.The Journal of infection. 2008, Vol 57, Num 5, pp 414-415, issn 0163-4453, 2 p.Article

Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivoLEIMING LI; XIAOYU LIN; SHOEMAKER, Alex R et al.Clinical cancer research. 2006, Vol 12, Num 15, pp 4747-4754, issn 1078-0432, 8 p.Article

MGMT methylation : A marker of response to temozolomide in low-grade gliomasEVERHARD, Sibille; KALOSHI, Gentian; DELATTRE, Jean-Yves et al.Annals of neurology. 2006, Vol 60, Num 6, pp 740-743, issn 0364-5134, 4 p.Article

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomasHOUILLIER, C; WANG, X; HOANG-XUAN, K et al.Neurology. 2010, Vol 75, Num 17, pp 1560-1566, issn 0028-3878, 7 p.Article

ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse TumorsPALMA, Joann P; WANG, Yi-Chun; ZHU, Gui-Dong et al.Clinical cancer research (Print). 2009, Vol 15, Num 23, pp 7277-7290, issn 1078-0432, 14 p.Article

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomideDUBBINK, H. J; TAAL, W; BOOGERD, W et al.Neurology. 2009, Vol 73, Num 21, pp 1792-1795, issn 0028-3878, 4 p.Article